Global Antacids Market Size, Share & Industry Trends Analysis Report By Formulation Type (Tablets, Liquids and Others), By Mechanism of Action (Non-systemic and Systemic), By Distribution Channel, By Regional Outlook and Forecast, 2023 - 2029

Global Antacids Market Size, Share & Industry Trends Analysis Report By Formulation Type (Tablets, Liquids and Others), By Mechanism of Action (Non-systemic and Systemic), By Distribution Channel, By Regional Outlook and Forecast, 2023 - 2029


The Global Antacids Market size is expected to reach $7.9 billion by 2029, rising at a market growth of 3.2% CAGR during the forecast period.

Antacids are widely used in the form of tablets as it is a preferred option for consumers due to their accessibility, convenience, and variety of flavors and formulations, hence tablets category generated $3,249 million in 2022. The prevalence of GERD in the US was estimated to be around 18.1-27.8% in 2022, as reported by the National Library of Medicine. In addition, the National GI Survey revealed that a sizable percentage of individuals experience GERD episodes twice a week, with many patients displaying the symptoms at least once a week. Some of the factors impacting the market are increased consumption of fast food causes digestive disorders like indigestion, Rapidly Increasing Geriatric Population Globally and Increasing availability of improved medications.

Due to the growing incidence of gastrointestinal symptoms, such as heartburn and acid reflux, among COVID-19 patients, the antacids sector saw a rise in demand. However, Because of the lockdowns and trade and movement restrictions, it was challenging for manufacturers to transport finished goods and procure raw materials, which resulted in a decline in supply and a rise in demand for antacids. This had a considerable supportive effect on the industry.

Fast food consumption has considerably expanded on a worldwide basis. Both allergies and obesity are associated with frequent fast-food intake. Therefore, as the consumption of fast foods is increasing rapidly among all age groups, it will increase the prevalence of stomach and digestive issues. This will significantly boost the growth of the market. By the year 2030, one out of every six people will be at least 60 years old. Over 60s will make up 1.4 billion individuals by this time, up from 1 billion in 2020. By 2050, there will be twice as many persons aged 60 or older, and it will reach a staggering 2.1 billion. Therefore, the market growth is anticipated to soar in the anticipated period due to the condition's higher prevalence among the elderly. However, H2 receptor antagonists and proton pump inhibitors (PPIs) are two examples of newer, more potent treatments for acid-related illnesses that are posing a challenge to the industry.

Mechanism of action Outlook

Based on mechanism of action, the market is characterized into systemic antacids and non-systemic antacids. The systemic antacids segment procured a considerable growth rate in the market in 2022. These antacids, like sodium bicarbonate, generate systemic alkalosis and are soluble and resorbable. The effervescence of bicarbonate shows an abundance of painkiller/antacid combos. In addition, these chemicals produce carbon dioxide when it reacts with the hydrochloric acid in the stomach; it is quickly absorbed but can occasionally result in a pleasant burp. The easy availability of these types of antacids is propelling the growth of the market.

Formulation Type Outlook

On the basis of formulation type, the market is classified into tablets, liquids, and others. The tablets segment acquired the largest revenue share in the market in 2022. The market's major players provide an assortment of antacid tablet products. Furthermore, the creation and introduction of chewable antacid pills have also increased the demand for tablets. All these factors are boosting the expansion of the segment.

Distribution Channel Outlook

By distribution channel, the market is divided into hospital pharmacies, drug stores & retail pharmacies, and online providers. The drug stores & retail pharmacies segment witnessed the maximum revenue share in the market in 2022. Due to the convenience these establishments provide for customers and the widespread availability of antacids, the drug stores & retail pharmacies sector led the market. Additionally, many people choose to buy over-the-counter antacids for occasional indigestion or heartburn rather than wanting a prescription drug or medical intervention, which furthers the segment's growth.

Regional Outlook

Region wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America segment procured the highest revenue share in the market in 2022. The expansion in North America is linked to the region's accessible, highly developed healthcare system, the presence of the most important players, the rise in cases of heartburn, and the simplicity of obtaining over-the-counter medications. Additionally, GERD, gastritis, and peptic ulcer disease are very common in the United States and other major North American nations, which increases the demand for antacid medications.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Alkem Laboratories Ltd., Bayer AG, Cipla Limited, Pfizer, Inc., Prestige Consumer Healthcare, Inc., Reckitt Benckiser Group PLC, WellSpring Pharmaceutical Corporation (Avista Capital Partners), Sanofi S.A. and Sun Pharmaceutical Industries Ltd.

Scope of the Study

Market Segments covered in the Report:

By Formulation Type
  • Tablets
  • Liquids
  • Others
By Mechanism of Action
  • Non-systemic
  • Systemic
By Distribution Channel
  • Drug Store & Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies
By Geography
  • North America
  • US
  • Canada
  • Mexico
  • Rest of North America
  • Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
  • LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA
Companies Profiled
  • Abbott Laboratories
  • Alkem Laboratories Ltd.
  • Bayer AG
  • Cipla Limited
  • Pfizer, Inc.
  • Prestige Consumer Healthcare, Inc.
  • Reckitt Benckiser Group PLC
  • WellSpring Pharmaceutical Corporation (Avista Capital Partners)
  • Sanofi S.A.
  • Sun Pharmaceutical Industries Ltd.
Unique Offerings from KBV Research
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Antacids Market, by Formulation Type
1.4.2 Global Antacids Market, by Mechanism of Action
1.4.3 Global Antacids Market, by Distribution Channel
1.4.4 Global Antacids Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Global Antacids Market by Formulation Type
3.1 Global Tablets Market by Region
3.2 Global Liquids Market by Region
3.3 Global Others Market by Region
Chapter 4. Global Antacids Market by Mechanism of Action
4.1 Global Non-systemic Market by Region
4.2 Global Systemic Market by Region
Chapter 5. Global Antacids Market by Distribution Channel
5.1 Global Drug Store & Retail Pharmacies Market by Region
5.2 Global Hospital Pharmacies Market by Region
5.3 Global Online Pharmacies Market by Region
Chapter 6. Global Antacids Market by Region
6.1 North America Antacids Market
6.1.1 North America Antacids Market by Formulation Type
6.1.1.1 North America Tablets Market by Country
6.1.1.2 North America Liquids Market by Country
6.1.1.3 North America Others Market by Country
6.1.2 North America Antacids Market by Mechanism of Action
6.1.2.1 North America Non-systemic Market by Country
6.1.2.2 North America Systemic Market by Country
6.1.3 North America Antacids Market by Distribution Channel
6.1.3.1 North America Drug Store & Retail Pharmacies Market by Country
6.1.3.2 North America Hospital Pharmacies Market by Country
6.1.3.3 North America Online Pharmacies Market by Country
6.1.4 North America Antacids Market by Country
6.1.4.1 US Antacids Market
6.1.4.1.1 US Antacids Market by Formulation Type
6.1.4.1.2 US Antacids Market by Mechanism of Action
6.1.4.1.3 US Antacids Market by Distribution Channel
6.1.4.2 Canada Antacids Market
6.1.4.2.1 Canada Antacids Market by Formulation Type
6.1.4.2.2 Canada Antacids Market by Mechanism of Action
6.1.4.2.3 Canada Antacids Market by Distribution Channel
6.1.4.3 Mexico Antacids Market
6.1.4.3.1 Mexico Antacids Market by Formulation Type
6.1.4.3.2 Mexico Antacids Market by Mechanism of Action
6.1.4.3.3 Mexico Antacids Market by Distribution Channel
6.1.4.4 Rest of North America Antacids Market
6.1.4.4.1 Rest of North America Antacids Market by Formulation Type
6.1.4.4.2 Rest of North America Antacids Market by Mechanism of Action
6.1.4.4.3 Rest of North America Antacids Market by Distribution Channel
6.2 Europe Antacids Market
6.2.1 Europe Antacids Market by Formulation Type
6.2.1.1 Europe Tablets Market by Country
6.2.1.2 Europe Liquids Market by Country
6.2.1.3 Europe Others Market by Country
6.2.2 Europe Antacids Market by Mechanism of Action
6.2.2.1 Europe Non-systemic Market by Country
6.2.2.2 Europe Systemic Market by Country
6.2.3 Europe Antacids Market by Distribution Channel
6.2.3.1 Europe Drug Store & Retail Pharmacies Market by Country
6.2.3.2 Europe Hospital Pharmacies Market by Country
6.2.3.3 Europe Online Pharmacies Market by Country
6.2.4 Europe Antacids Market by Country
6.2.4.1 Germany Antacids Market
6.2.4.1.1 Germany Antacids Market by Formulation Type
6.2.4.1.2 Germany Antacids Market by Mechanism of Action
6.2.4.1.3 Germany Antacids Market by Distribution Channel
6.2.4.2 UK Antacids Market
6.2.4.2.1 UK Antacids Market by Formulation Type
6.2.4.2.2 UK Antacids Market by Mechanism of Action
6.2.4.2.3 UK Antacids Market by Distribution Channel
6.2.4.3 France Antacids Market
6.2.4.3.1 France Antacids Market by Formulation Type
6.2.4.3.2 France Antacids Market by Mechanism of Action
6.2.4.3.3 France Antacids Market by Distribution Channel
6.2.4.4 Russia Antacids Market
6.2.4.4.1 Russia Antacids Market by Formulation Type
6.2.4.4.2 Russia Antacids Market by Mechanism of Action
6.2.4.4.3 Russia Antacids Market by Distribution Channel
6.2.4.5 Spain Antacids Market
6.2.4.5.1 Spain Antacids Market by Formulation Type
6.2.4.5.2 Spain Antacids Market by Mechanism of Action
6.2.4.5.3 Spain Antacids Market by Distribution Channel
6.2.4.6 Italy Antacids Market
6.2.4.6.1 Italy Antacids Market by Formulation Type
6.2.4.6.2 Italy Antacids Market by Mechanism of Action
6.2.4.6.3 Italy Antacids Market by Distribution Channel
6.2.4.7 Rest of Europe Antacids Market
6.2.4.7.1 Rest of Europe Antacids Market by Formulation Type
6.2.4.7.2 Rest of Europe Antacids Market by Mechanism of Action
6.2.4.7.3 Rest of Europe Antacids Market by Distribution Channel
6.3 Asia Pacific Antacids Market
6.3.1 Asia Pacific Antacids Market by Formulation Type
6.3.1.1 Asia Pacific Tablets Market by Country
6.3.1.2 Asia Pacific Liquids Market by Country
6.3.1.3 Asia Pacific Others Market by Country
6.3.2 Asia Pacific Antacids Market by Mechanism of Action
6.3.2.1 Asia Pacific Non-systemic Market by Country
6.3.2.2 Asia Pacific Systemic Market by Country
6.3.3 Asia Pacific Antacids Market by Distribution Channel
6.3.3.1 Asia Pacific Drug Store & Retail Pharmacies Market by Country
6.3.3.2 Asia Pacific Hospital Pharmacies Market by Country
6.3.3.3 Asia Pacific Online Pharmacies Market by Country
6.3.4 Asia Pacific Antacids Market by Country
6.3.4.1 China Antacids Market
6.3.4.1.1 China Antacids Market by Formulation Type
6.3.4.1.2 China Antacids Market by Mechanism of Action
6.3.4.1.3 China Antacids Market by Distribution Channel
6.3.4.2 Japan Antacids Market
6.3.4.2.1 Japan Antacids Market by Formulation Type
6.3.4.2.2 Japan Antacids Market by Mechanism of Action
6.3.4.2.3 Japan Antacids Market by Distribution Channel
6.3.4.3 India Antacids Market
6.3.4.3.1 India Antacids Market by Formulation Type
6.3.4.3.2 India Antacids Market by Mechanism of Action
6.3.4.3.3 India Antacids Market by Distribution Channel
6.3.4.4 South Korea Antacids Market
6.3.4.4.1 South Korea Antacids Market by Formulation Type
6.3.4.4.2 South Korea Antacids Market by Mechanism of Action
6.3.4.4.3 South Korea Antacids Market by Distribution Channel
6.3.4.5 Singapore Antacids Market
6.3.4.5.1 Singapore Antacids Market by Formulation Type
6.3.4.5.2 Singapore Antacids Market by Mechanism of Action
6.3.4.5.3 Singapore Antacids Market by Distribution Channel
6.3.4.6 Malaysia Antacids Market
6.3.4.6.1 Malaysia Antacids Market by Formulation Type
6.3.4.6.2 Malaysia Antacids Market by Mechanism of Action
6.3.4.6.3 Malaysia Antacids Market by Distribution Channel
6.3.4.7 Rest of Asia Pacific Antacids Market
6.3.4.7.1 Rest of Asia Pacific Antacids Market by Formulation Type
6.3.4.7.2 Rest of Asia Pacific Antacids Market by Mechanism of Action
6.3.4.7.3 Rest of Asia Pacific Antacids Market by Distribution Channel
6.4 LAMEA Antacids Market
6.4.1 LAMEA Antacids Market by Formulation Type
6.4.1.1 LAMEA Tablets Market by Country
6.4.1.2 LAMEA Liquids Market by Country
6.4.1.3 LAMEA Others Market by Country
6.4.2 LAMEA Antacids Market by Mechanism of Action
6.4.2.1 LAMEA Non-systemic Market by Country
6.4.2.2 LAMEA Systemic Market by Country
6.4.3 LAMEA Antacids Market by Distribution Channel
6.4.3.1 LAMEA Drug Store & Retail Pharmacies Market by Country
6.4.3.2 LAMEA Hospital Pharmacies Market by Country
6.4.3.3 LAMEA Online Pharmacies Market by Country
6.4.4 LAMEA Antacids Market by Country
6.4.4.1 Brazil Antacids Market
6.4.4.1.1 Brazil Antacids Market by Formulation Type
6.4.4.1.2 Brazil Antacids Market by Mechanism of Action
6.4.4.1.3 Brazil Antacids Market by Distribution Channel
6.4.4.2 Argentina Antacids Market
6.4.4.2.1 Argentina Antacids Market by Formulation Type
6.4.4.2.2 Argentina Antacids Market by Mechanism of Action
6.4.4.2.3 Argentina Antacids Market by Distribution Channel
6.4.4.3 UAE Antacids Market
6.4.4.3.1 UAE Antacids Market by Formulation Type
6.4.4.3.2 UAE Antacids Market by Mechanism of Action
6.4.4.3.3 UAE Antacids Market by Distribution Channel
6.4.4.4 Saudi Arabia Antacids Market
6.4.4.4.1 Saudi Arabia Antacids Market by Formulation Type
6.4.4.4.2 Saudi Arabia Antacids Market by Mechanism of Action
6.4.4.4.3 Saudi Arabia Antacids Market by Distribution Channel
6.4.4.5 South Africa Antacids Market
6.4.4.5.1 South Africa Antacids Market by Formulation Type
6.4.4.5.2 South Africa Antacids Market by Mechanism of Action
6.4.4.5.3 South Africa Antacids Market by Distribution Channel
6.4.4.6 Nigeria Antacids Market
6.4.4.6.1 Nigeria Antacids Market by Formulation Type
6.4.4.6.2 Nigeria Antacids Market by Mechanism of Action
6.4.4.6.3 Nigeria Antacids Market by Distribution Channel
6.4.4.7 Rest of LAMEA Antacids Market
6.4.4.7.1 Rest of LAMEA Antacids Market by Formulation Type
6.4.4.7.2 Rest of LAMEA Antacids Market by Mechanism of Action
6.4.4.7.3 Rest of LAMEA Antacids Market by Distribution Channel
Chapter 7. Company Profiles
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 SWOT Analysis
7.2 Alkem Laboratories Ltd.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expenses
7.3 Bayer AG
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.3.5 SWOT Analysis
7.4 Cipla Limited
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Regional Analysis
7.4.4 Research & Development Expense
7.5 Pfizer, Inc.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Regional & Segmental Analysis
7.5.4 Research & Development Expense
7.6 Prestige Consumer Healthcare, Inc.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.7 Reckitt Benckiser Group PLC
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expenses
7.8 WellSpring Pharmaceutical Corporation (Avista Capital Partners)
7.8.1 Company Overview
7.9 Sanofi S.A.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expense
7.10. Sun Pharmaceutical Industries Ltd.
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Regional Analysis
7.10.4 Research & Development Expenses

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings